1. Home >
  2. M&A >
  3. Buyout (LBO, MBO, MBI) >
  4. New Zealand >
  5. Pencarrow Private Equity Acquires Pacific Clinical Research Network

M&A Deal Summary

Pencarrow Private Equity Acquires Pacific Clinical Research Network

On October 26, 2021, private equity firm Pencarrow Private Equity acquired life science company Pacific Clinical Research Network

Acquisition Highlights
  • This is Pencarrow Private Equity’s 1st transaction in the Life Science sector.
  • This is Pencarrow Private Equity’s 21st transaction in New Zealand.

M&A Deal Summary
Date 2021-10-26
Target Pacific Clinical Research Network
Sector Life Science
Buyer(s) Pencarrow Private Equity
Deal Type Buyout (LBO, MBO, MBI)

Target

Pacific Clinical Research Network

Auckland, New Zealand
Pacific Clinical Research Network (PCRN) comprises of two clinical trials businesses (Lakeland Clinical Trials Group and Southern Clinical Trials Group) that perform the administration of new pharmaceuticals and medical devices under controlled conditions as part of a clinical trial, with a focus on phase 1b to 4 clinical trials. PCRN operates two sites directly, in Rotorua and Christchurch, and has a separate franchise network of ten additional sites across New Zealand. Pacific Clinical Research Network is based in Auckland, New Zealand.

Search 214,238 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Pencarrow Private Equity

Wellington, New Zealand

Investor Investor Investor Investor

Category Private Equity Firm
Founded 1993
PE ASSETS 692M NZD
Size Middle-Market
Type Sector Agnostic
DESCRIPTION

Pencarrow Private Equity is a private equity firm focused on investing in New Zealand owned and operated businesses. Pencarrow looks to support management buyouts, management buy-ins, and provide expansion capital for companies operating in a variety of sectors. Areas of interest include building materials, distribution, manufacturing, consumer products, business services, and capital equipment. Target companies are typically valued between NZ$20 and $150 million where the Firm can commit $10 to $30 million in equity capital. Pencarrow Private Equity was formed in 1993 and is based in Wellington, New Zealand.

DEAL STATS #
Overall 22 of 24
Sector: Life Science M&A 1 of 1
Type: Buyout (LBO, MBO, MBI) M&A Deals 10 of 11
Country: New Zealand M&A 21 of 23
Year: 2021 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2021-09-30 Interiors Group

Auckland, New Zealand

Interiors Group is a specialist provider of flooring and window furnishings operating through both company owned and franchised stores. The Interiors Group operates through the Carpet Court, CurtainStudio and The Floor Store brands, and offers a wide range of exclusive and own branded products. Interiors Group is based in Auckland, New Zealand.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2022-05-03 MMC

Auckland, New Zealand

MMC is a specialist fund and investment administration business. The company provides fund accounting and unit pricing services for over 210 investment funds and has over $30 billion of clients' funds under its administration. It also offers settlement functions, registry services, trade matching plus valuation, returns and accounting services. MMC is based in Auckland, New Zealand.

Sell -
Mergr

Solution for

Product

Company

Legal